Selected research
Market Structure
Global Cobalt Chromium Coronary Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cobalt Chromium Coronary Stent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Cobalt Chromium Coronary Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cobalt Chromium Coronary Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cobalt Chromium Coronary Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cobalt Chromium Coronary Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cobalt Chromium Coronary Stent include Alvimedica, Balton, Biosensors, Biotronik, Celonova, Elixir Medical, Essen Technology, Lepu Medical and Nano Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Cobalt Chromium Coronary Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cobalt Chromium Coronary Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cobalt Chromium Coronary Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cobalt Chromium Coronary Stent market size, projected growth trends, production technologies, key applications, and end-use industries.
Cobalt Chromium Coronary Stent Segment by Company
Alvimedica
Balton
Biosensors
Biotronik
Celonova
Elixir Medical
Essen Technology
Lepu Medical
Nano Therapeutics
NET
Relisys Medical Devices
Rontis Medical
SLTL Medical
Boston Scientific
Medtronic
Terumo
Cobalt Chromium Coronary Stent Segment by Type
Bare-metal Stent (BMS)
Bioresorbable Vascular Scaffold (BVS)
Drug-eluting Stent (DES)
Cobalt Chromium Coronary Stent Segment by Application
Post-Procedure Management
Percutaneous Coronary Intervention (PCI)
Others
Cobalt Chromium Coronary Stent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobalt Chromium Coronary Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cobalt Chromium Coronary Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobalt Chromium Coronary Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Cobalt Chromium Coronary Stent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cobalt Chromium Coronary Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cobalt Chromium Coronary Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Cobalt Chromium Coronary Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Bare-metal Stent (BMS)
- Bioresorbable Vascular Scaffold (BVS)
- Drug-eluting Stent (DES)
Applications
- Post-Procedure Management
- Percutaneous Coronary Intervention (PCI)
- Others
Companies covered
- Alvimedica
- Balton
- Biosensors
- Biotronik
- Celonova
- Elixir Medical
- Essen Technology
- Lepu Medical
- Nano Therapeutics
- NET
- Relisys Medical Devices
- Rontis Medical
- SLTL Medical
- Boston Scientific
- Medtronic
- Terumo
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Cobalt Chromium Coronary Stent Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Cobalt Chromium Coronary Stent Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Cobalt Chromium Coronary Stent Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Cobalt Chromium Coronary Stent Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Cobalt Chromium Coronary Stent Market Dynamics
- 2.1 Cobalt Chromium Coronary Stent Industry Trends
- 2.2 Cobalt Chromium Coronary Stent Industry Drivers
- 2.3 Cobalt Chromium Coronary Stent Industry Opportunities and Challenges
- 2.4 Cobalt Chromium Coronary Stent Industry Restraints
3 Cobalt Chromium Coronary Stent Market by Manufacturers
- 3.1 Global Cobalt Chromium Coronary Stent Revenue by Manufacturers (2021-2026)
- 3.2 Global Cobalt Chromium Coronary Stent Sales by Manufacturers (2021-2026)
- 3.3 Global Cobalt Chromium Coronary Stent Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Cobalt Chromium Coronary Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cobalt Chromium Coronary Stent Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Cobalt Chromium Coronary Stent Manufacturers, Product Type & Application
- 3.7 Global Cobalt Chromium Coronary Stent Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cobalt Chromium Coronary Stent Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cobalt Chromium Coronary Stent Players Market Share by Revenue in 2025
- 3.8.3 2025 Cobalt Chromium Coronary Stent Tier 1, Tier 2, and Tier 3
4 Cobalt Chromium Coronary Stent Market by Type
- 4.1 Cobalt Chromium Coronary Stent Type Introduction
- 4.1.1 Bare-metal Stent (BMS)
- 4.1.2 Bioresorbable Vascular Scaffold (BVS)
- 4.1.3 Drug-eluting Stent (DES)
- 4.2 Global Cobalt Chromium Coronary Stent Sales by Type
- 4.2.1 Global Cobalt Chromium Coronary Stent Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Cobalt Chromium Coronary Stent Sales by Type (2021-2032)
- 4.2.3 Global Cobalt Chromium Coronary Stent Sales Market Share by Type (2021-2032)
- 4.3 Global Cobalt Chromium Coronary Stent Revenue by Type
- 4.3.1 Global Cobalt Chromium Coronary Stent Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Cobalt Chromium Coronary Stent Revenue by Type (2021-2032)
- 4.3.3 Global Cobalt Chromium Coronary Stent Revenue Market Share by Type (2021-2032)
5 Cobalt Chromium Coronary Stent Market by Application
- 5.1 Cobalt Chromium Coronary Stent Application Introduction
- 5.1.1 Post-Procedure Management
- 5.1.2 Percutaneous Coronary Intervention (PCI)
- 5.1.3 Others
- 5.2 Global Cobalt Chromium Coronary Stent Sales by Application
- 5.2.1 Global Cobalt Chromium Coronary Stent Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Cobalt Chromium Coronary Stent Sales by Application (2021-2032)
- 5.2.3 Global Cobalt Chromium Coronary Stent Sales Market Share by Application (2021-2032)
- 5.3 Global Cobalt Chromium Coronary Stent Revenue by Application
- 5.3.1 Global Cobalt Chromium Coronary Stent Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Cobalt Chromium Coronary Stent Revenue by Application (2021-2032)
- 5.3.3 Global Cobalt Chromium Coronary Stent Revenue Market Share by Application (2021-2032)
6 Global Cobalt Chromium Coronary Stent Sales by Region
- 6.1 Global Cobalt Chromium Coronary Stent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Cobalt Chromium Coronary Stent Sales by Region (2021-2032)
- 6.2.1 Global Cobalt Chromium Coronary Stent Sales by Region (2021-2026)
- 6.2.2 Global Cobalt Chromium Coronary Stent Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Cobalt Chromium Coronary Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Cobalt Chromium Coronary Stent Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Cobalt Chromium Coronary Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Cobalt Chromium Coronary Stent Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Cobalt Chromium Coronary Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Cobalt Chromium Coronary Stent Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Cobalt Chromium Coronary Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Cobalt Chromium Coronary Stent Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Cobalt Chromium Coronary Stent Revenue by Region
- 7.1 Global Cobalt Chromium Coronary Stent Revenue by Region
- 7.1.1 Global Cobalt Chromium Coronary Stent Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Cobalt Chromium Coronary Stent Revenue by Region (2021-2026)
- 7.1.3 Global Cobalt Chromium Coronary Stent Revenue by Region (2027-2032)
- 7.1.4 Global Cobalt Chromium Coronary Stent Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Cobalt Chromium Coronary Stent Revenue (2021-2032)
- 7.2.2 North America Cobalt Chromium Coronary Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Cobalt Chromium Coronary Stent Revenue (2021-2032)
- 7.3.2 Europe Cobalt Chromium Coronary Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Cobalt Chromium Coronary Stent Revenue (2021-2032)
- 7.4.2 Asia-Pacific Cobalt Chromium Coronary Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Cobalt Chromium Coronary Stent Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Cobalt Chromium Coronary Stent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Alvimedica
- 8.1.1 Alvimedica Company Information
- 8.1.2 Alvimedica Business Overview
- 8.1.3 Alvimedica Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Alvimedica Cobalt Chromium Coronary Stent Product Portfolio
- 8.1.5 Alvimedica Recent Developments
- 8.2 Balton
- 8.2.1 Balton Company Information
- 8.2.2 Balton Business Overview
- 8.2.3 Balton Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Balton Cobalt Chromium Coronary Stent Product Portfolio
- 8.2.5 Balton Recent Developments
- 8.3 Biosensors
- 8.3.1 Biosensors Company Information
- 8.3.2 Biosensors Business Overview
- 8.3.3 Biosensors Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Biosensors Cobalt Chromium Coronary Stent Product Portfolio
- 8.3.5 Biosensors Recent Developments
- 8.4 Biotronik
- 8.4.1 Biotronik Company Information
- 8.4.2 Biotronik Business Overview
- 8.4.3 Biotronik Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Biotronik Cobalt Chromium Coronary Stent Product Portfolio
- 8.4.5 Biotronik Recent Developments
- 8.5 Celonova
- 8.5.1 Celonova Company Information
- 8.5.2 Celonova Business Overview
- 8.5.3 Celonova Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Celonova Cobalt Chromium Coronary Stent Product Portfolio
- 8.5.5 Celonova Recent Developments
- 8.6 Elixir Medical
- 8.6.1 Elixir Medical Company Information
- 8.6.2 Elixir Medical Business Overview
- 8.6.3 Elixir Medical Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Elixir Medical Cobalt Chromium Coronary Stent Product Portfolio
- 8.6.5 Elixir Medical Recent Developments
- 8.7 Essen Technology
- 8.7.1 Essen Technology Company Information
- 8.7.2 Essen Technology Business Overview
- 8.7.3 Essen Technology Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Essen Technology Cobalt Chromium Coronary Stent Product Portfolio
- 8.7.5 Essen Technology Recent Developments
- 8.8 Lepu Medical
- 8.8.1 Lepu Medical Company Information
- 8.8.2 Lepu Medical Business Overview
- 8.8.3 Lepu Medical Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Lepu Medical Cobalt Chromium Coronary Stent Product Portfolio
- 8.8.5 Lepu Medical Recent Developments
- 8.9 Nano Therapeutics
- 8.9.1 Nano Therapeutics Company Information
- 8.9.2 Nano Therapeutics Business Overview
- 8.9.3 Nano Therapeutics Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Nano Therapeutics Cobalt Chromium Coronary Stent Product Portfolio
- 8.9.5 Nano Therapeutics Recent Developments
- 8.10 NET
- 8.10.1 NET Company Information
- 8.10.2 NET Business Overview
- 8.10.3 NET Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 NET Cobalt Chromium Coronary Stent Product Portfolio
- 8.10.5 NET Recent Developments
- 8.11 Relisys Medical Devices
- 8.11.1 Relisys Medical Devices Company Information
- 8.11.2 Relisys Medical Devices Business Overview
- 8.11.3 Relisys Medical Devices Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Relisys Medical Devices Cobalt Chromium Coronary Stent Product Portfolio
- 8.11.5 Relisys Medical Devices Recent Developments
- 8.12 Rontis Medical
- 8.12.1 Rontis Medical Company Information
- 8.12.2 Rontis Medical Business Overview
- 8.12.3 Rontis Medical Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Rontis Medical Cobalt Chromium Coronary Stent Product Portfolio
- 8.12.5 Rontis Medical Recent Developments
- 8.13 SLTL Medical
- 8.13.1 SLTL Medical Company Information
- 8.13.2 SLTL Medical Business Overview
- 8.13.3 SLTL Medical Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 SLTL Medical Cobalt Chromium Coronary Stent Product Portfolio
- 8.13.5 SLTL Medical Recent Developments
- 8.14 Boston Scientific
- 8.14.1 Boston Scientific Company Information
- 8.14.2 Boston Scientific Business Overview
- 8.14.3 Boston Scientific Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Boston Scientific Cobalt Chromium Coronary Stent Product Portfolio
- 8.14.5 Boston Scientific Recent Developments
- 8.15 Medtronic
- 8.15.1 Medtronic Company Information
- 8.15.2 Medtronic Business Overview
- 8.15.3 Medtronic Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Medtronic Cobalt Chromium Coronary Stent Product Portfolio
- 8.15.5 Medtronic Recent Developments
- 8.16 Terumo
- 8.16.1 Terumo Company Information
- 8.16.2 Terumo Business Overview
- 8.16.3 Terumo Cobalt Chromium Coronary Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Terumo Cobalt Chromium Coronary Stent Product Portfolio
- 8.16.5 Terumo Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Cobalt Chromium Coronary Stent Value Chain Analysis
- 9.1.1 Cobalt Chromium Coronary Stent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Cobalt Chromium Coronary Stent Production Mode & Process
- 9.2 Cobalt Chromium Coronary Stent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Cobalt Chromium Coronary Stent Distributors
- 9.2.3 Cobalt Chromium Coronary Stent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst